股本结构
单位：万股
| 公告日期 | 2026-08-13 | 2026-08-13 | 2026-05-07 | 2026-04-24 | 2026-05-07 | 2026-03-05 |
|---|---|---|---|---|---|---|
| 证券总股本 | 10720.75 | 10599.57 | 9918.06 | 9868.24 | 9695.12 | 9663.72 |
| 普通股本 | 10720.75 | 10599.57 | 9918.06 | 9868.24 | 9695.12 | 9663.72 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-08-07 | 2026-06-30 | 2026-04-30 | 2026-04-20 | 2026-03-31 | 2026-02-27 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-13 | 10720.75 | 未披露 | 定期报告 | 2026-08-07 |
| 2026-08-13 | 10599.57 | 未披露 |
更多>>
From March 31, 2026 to June 30, 2026
Issuances of common stock on exercise of options
Issuances of common stock in connection with ATM offering, net of offering expenses
Issuances of common stock upon vesting of RSUs
|
2026-06-30 |
| 2026-05-07 | 9918.06 | 未披露 | 定期报告 | 2026-04-30 |
| 2026-04-24 | 9868.24 | 未披露 | 定期报告 | 2026-04-20 |
| 2026-05-07 | 9695.12 | 未披露 |
更多>>
From December 31,2025 to March 31, 2026
Issuances of common stock under ESPP
Issuances of common stock on exercise of options
Issuances of common stock in connection with ATM offering, net of offering expenses
Issuances of common stock upon vesting of RSUs
|
2026-03-31 |
| 2026-03-05 | 9663.72 | 未披露 | 定期报告 | 2026-02-27 |
| 2026-03-05 | 9514.37 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Issuances of common stock under ESPP
Issuances of common stock on exercises of options
Issuances of common stock upon vesting of RSUs
Issuances of common stock in connection with ATM offering, net of offering expenses
|
2025-12-31 |
| 2025-11-12 | 9346.80 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Issuances of common stock under ESPP
Issuances of common stock upon vesting of RSUs
|
2025-09-30 |
| 2025-08-12 | 9312.32 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Issuances of common stock on exercises of options
Issuances of common stock upon vesting of RSUs
|
2025-06-30 |
| 2025-03-10 | 9300.46 | 未披露 | 定期报告 | 2025-03-04 |
| 2025-03-10 | 9237.86 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuances of common stock upon vesting of RSUs
Issuances of common stock in connection with ATM offering, net of offering expenses
Issuances of common stock under ESPP
Issuances of common stock on exercises of options
|
2024-12-31 |
| 2024-11-06 | 9055.27 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Issuances of common stock under ESPP
Issuances of common stock upon vesting of RSUs
Issuances of common stock in connection with follow-on public offering, net of offering expenses
|
2024-09-30 |
| 2024-08-06 | 9036.28 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common stock on exercise of options
Issuance of common stock under ESPP
|
2024-06-30 |
| 2024-04-25 | 9031.78 | 未披露 | 定期报告 | 2024-04-15 |
| 2024-03-11 | 9031.45 | 未披露 | 定期报告 | 2024-03-05 |
| 2024-03-11 | 8844.89 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common stock under employee stock plans
Issuance of common stock on exercise of options
Issuance of common stock on RSU release
Issuance of common stock in connection with public follow-on offering, net of offering expenses
Issuance of common stock in connection with at-the-market offering, net of offering expenses
Issuance of common stock pursuant to a private placement with Pfizer
|
2023-12-31 |
| 2023-11-07 | 8843.11 | 未披露 | 定期报告 | 2023-11-02 |
| 2023-11-07 | 8843.06 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock on exercise of options
Issuance of common stock on RSU release
Issuance of common stock under employee stock plans
Issuance of common stock in connection with follow-on public offering, net of offering expenses
|
2023-09-30 |
| 2023-08-08 | 8828.48 | 未披露 | 定期报告 | 2023-08-03 |
| 2023-07-14 | 8059.45 | 未披露 |
更多>>
Common Stock offered 19,230,769 shares by the company
|
2023-07-18 |
| 2023-08-08 | 6610.00 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock on exercise of options
Issuance of common stock pursuant to a private placement with Pfizer
|
2023-06-30 |
| 2023-05-09 | 6136.37 | 未披露 | 定期报告 | 2023-05-04 |
| 2023-04-28 | 6134.38 | 未披露 | 定期报告 | 2023-04-17 |
| 2023-05-09 | 6132.35 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock under employee stock plans
Issuance of common stock on exercise of options
Issuance of common stock in connection with at-the-market offering, net of offering expenses
|
2023-03-31 |
| 2023-03-09 | 6129.97 | 未披露 | 定期报告 | 2023-03-03 |
| 2023-03-09 | 6102.92 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock on exercise of options
Issuance of common stock under employee stock plans
|
2022-12-31 |
| 2022-11-08 | 6100.16 | 未披露 | 定期报告 | 2022-11-03 |
| 2022-11-08 | 6098.69 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock on exercise of options
|
2022-09-30 |
| 2022-08-11 | 6084.08 | 未披露 | 定期报告 | 2022-08-04 |
| 2022-08-09 | 6084.04 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-08-09 | 6083.84 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock on exercise of options
|
2022-06-30 |
| 2022-05-09 | 6070.54 | 未披露 | 定期报告 | 2022-05-04 |
| 2022-05-09 | 6068.96 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock under employee stock plans
Issuance of common stock on exercise of options
|
2022-03-31 |
| 2022-03-21 | 6066.36 | 未披露 | 定期报告 | 2022-03-17 |
| 2022-03-21 | 6026.32 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of Series C convertible preferred stock, net of issuance costs of $6.2 million
Conversion of convertible preferred stock into common stock
Issuance of common stock upon initial public offering, net of issuance costs of $28.6 million
Issuance of common stock on exercise of options
|
2021-12-31 |
| 2021-11-09 | 6019.21 | 未披露 | 定期报告 | 2021-11-05 |
| 2021-11-09 | 6002.13 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Conversion of convertible preferred stock into common stock
Issuance of common stock upon initial public offering, net of issuance costs of $28.6 million
Issuance of common stock on exercise of options
|
2021-09-30 |
| 2021-09-02 | 5997.08 | 未披露 | 定期报告 | 2021-08-31 |
| 2021-07-23 | 5670.92 | 未披露 |
更多>>
1.Common stock offered by company 19,000,000 shares
2.The number of shares of common stock to be outstanding following this offering is based on 37,709,191 shares of common stock outstanding as of July 12, 2021
|
2021-07-23 |
From March 31, 2026 to June 30, 2026
Issuances of common stock on exercise of options
Issuances of common stock in connection with ATM offering, net of offering expenses
Issuances of common stock upon vesting of RSUs
From December 31,2025 to March 31, 2026
Issuances of common stock under ESPP
Issuances of common stock on exercise of options
Issuances of common stock in connection with ATM offering, net of offering expenses
Issuances of common stock upon vesting of RSUs
From December 31, 2024 to December 31, 2025
Issuances of common stock under ESPP
Issuances of common stock on exercises of options
Issuances of common stock upon vesting of RSUs
Issuances of common stock in connection with ATM offering, net of offering expenses
From June 30, 2025 to September 30, 2025
Issuances of common stock under ESPP
Issuances of common stock upon vesting of RSUs
From March 31, 2025 to June 30, 2025
Issuances of common stock on exercises of options
Issuances of common stock upon vesting of RSUs
From December 31, 2023 to December 31, 2024
Issuances of common stock upon vesting of RSUs
Issuances of common stock in connection with ATM offering, net of offering expenses
Issuances of common stock under ESPP
Issuances of common stock on exercises of options
From June 30, 2024 to September 30, 2024
Issuances of common stock under ESPP
Issuances of common stock upon vesting of RSUs
Issuances of common stock in connection with follow-on public offering, net of offering expenses
From March 31, 2024 to June 30, 2024
Issuance of common stock on exercise of options
Issuance of common stock under ESPP
From December 31,2022 to December 31,2023
Issuance of common stock under employee stock plans
Issuance of common stock on exercise of options
Issuance of common stock on RSU release
Issuance of common stock in connection with public follow-on offering, net of offering expenses
Issuance of common stock in connection with at-the-market offering, net of offering expenses
Issuance of common stock pursuant to a private placement with Pfizer
From June 30, 2023 to September 30, 2023
Issuance of common stock on exercise of options
Issuance of common stock on RSU release
Issuance of common stock under employee stock plans
Issuance of common stock in connection with follow-on public offering, net of offering expenses
Common Stock offered 19,230,769 shares by the company
From March 31, 2023 to June 30, 2023
Issuance of common stock on exercise of options
Issuance of common stock pursuant to a private placement with Pfizer
From December 31, 2022 to March 31, 2023
Issuance of common stock under employee stock plans
Issuance of common stock on exercise of options
Issuance of common stock in connection with at-the-market offering, net of offering expenses
From December 31, 2021 to December 31, 2022
Issuance of common stock on exercise of options
Issuance of common stock under employee stock plans
From June 30, 2022 to September 30, 2022
Issuance of common stock on exercise of options
From March 31, 2022 to June 30, 2022
Issuance of common stock on exercise of options
From December 31, 2021 to March 31, 2022
Issuance of common stock under employee stock plans
Issuance of common stock on exercise of options
From December 31, 2020 to December 31, 2021
Issuance of Series C convertible preferred stock, net of issuance costs of $6.2 million
Conversion of convertible preferred stock into common stock
Issuance of common stock upon initial public offering, net of issuance costs of $28.6 million
Issuance of common stock on exercise of options
From June 30, 2021 to September 30, 2021
Conversion of convertible preferred stock into common stock
Issuance of common stock upon initial public offering, net of issuance costs of $28.6 million
Issuance of common stock on exercise of options
1.Common stock offered by company 19,000,000 shares
2.The number of shares of common stock to be outstanding following this offering is based on 37,709,191 shares of common stock outstanding as of July 12, 2021